| 000 | 01275 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514054714.0 | ||
| 264 | 0 | _c20030317 | |
| 008 | 200303s 0 0 eng d | ||
| 022 | _a0340-5354 | ||
| 024 | 7 |
_a10.1007/s00415-002-1311-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRiederer, P | |
| 245 | 0 | 0 |
_aPractical importance of neuroprotection in Parkinson's disease. _h[electronic resource] |
| 260 |
_bJournal of neurology _cOct 2002 |
||
| 300 |
_aIII/53-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAmantadine _xtherapeutic use |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDopamine Agonists _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xtherapeutic use |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aParkinson Disease _xtherapy |
| 650 | 0 | 4 |
_aSelegiline _xtherapeutic use |
| 700 | 1 | _aGille, G | |
| 700 | 1 | _aMüller, T | |
| 700 | 1 | _aPrzuntek, H | |
| 700 | 1 | _aReichmann, H | |
| 700 | 1 | _aRiess, O | |
| 700 | 1 | _aSchwartz, A | |
| 700 | 1 | _aSchwarz, J | |
| 700 | 1 | _aVogt, T | |
| 773 | 0 |
_tJournal of neurology _gvol. 249 Suppl 3 _gp. III/53-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00415-002-1311-2 _zAvailable from publisher's website |
| 999 |
_c12325030 _d12325030 |
||